Related Experiment Video
Updated: May 30, 2026

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
Published on: June 10, 2025
How do I transfuse platelets (PLTs) to reverse anti-PLT drug effect?
1Department of Pathology, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-9073, USA. ravi.sarode@utsouthwestern.edu
Reversing potent antiplatelet agents (APAs) is crucial for patients with serious bleeding or urgent surgery. This article outlines a personal approach to platelet transfusion and pharmacologic reversal due to a lack of established guidelines.
Area of Science:
- Cardiology
- Hematology
- Pharmacology
Background:
- Antiplatelet agents (APAs) are vital for preventing arterial thrombotic disorders.
- Newer APAs offer increased potency but carry higher bleeding risks.
- Managing patients on APAs requiring urgent intervention presents a clinical challenge.
Purpose of the Study:
- To describe a clinical approach for reversing antiplatelet agents in patients with serious bleeding or requiring urgent surgery.
- To address the current lack of established guidelines for managing these complex cases.
Main Methods:
- The article details a personal, experience-based approach.
- It considers platelet transfusion and pharmacologic agents for APA reversal.
- Limited published data informs the described management strategy.
Main Results:
- No specific results are presented as this is an approach-based article.
- The focus is on a proposed management strategy rather than empirical findings.
Conclusions:
- There is an unmet need for clear guidelines on reversing antiplatelet agents.
- The described approach offers a potential framework for managing critical situations involving APAs.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Clot Retraction and Fibrinolysis
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care

